Foghorn Therapeutics Inc (FHTX)

Apr 30, 2026

[ARS] Foghorn Therapeutics Inc. SEC Filing - Stock Titan

Apr 30, 2026

Apr 30, 2026

Executive pay, major holders and votes in Foghorn (NASDAQ: FHTX) 2026 proxy - Stock Titan

Apr 30, 2026

Apr 30, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Apr 30, 2026

Apr 28, 2026

Foghorn Therapeutics (NASDAQ:FHTX) Stock Price Down 1.9%Time to Sell? - MarketBeat

Apr 28, 2026

Apr 27, 2026

Stifel reiterates Foghorn Therapeutics stock rating on AACR data - Investing.com

Apr 27, 2026

Apr 27, 2026

Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN

Apr 27, 2026

Apr 23, 2026

Should I sell Foghorn Therapeutics (FHTX) stock today | Q4 2025: Earnings UnderperformExpert Momentum Signals - Xã Châu Thành

Apr 23, 2026

Apr 22, 2026

H.C. Wainwright reiterates Foghorn Therapeutics stock rating at buy By Investing.com - Investing.com India

Apr 22, 2026

Apr 22, 2026

H.C. Wainwright reiterates Foghorn Therapeutics stock rating at buy - Investing.com

Apr 22, 2026

Apr 22, 2026

Foghorn presents preclinical data for cancer drug candidates By Investing.com - Investing.com South Africa

Apr 22, 2026

Apr 21, 2026

FHTX Unveils Promising Preclinical Data at AACR Annual Meeting - GuruFocus

Apr 21, 2026

Apr 21, 2026

Foghorn presents preclinical data for cancer drug candidates - Investing.com

Apr 21, 2026

Apr 21, 2026

Foghorn Highlights Preclinical Chromatin Oncology Advances at AACR - TipRanks

Apr 21, 2026

Apr 21, 2026

Foghorn Therapeutics presents new preclinical data on SMARCA2 inhibitor FHD-909 and targeted degrader programs - Traders Union

Apr 21, 2026

Apr 21, 2026

Foghorn Therapeutics Presents New Preclinical Data for - GlobeNewswire

Apr 21, 2026

Apr 21, 2026

Foghorn Therapeutics (Nasdaq: FHTX) showcases broad preclinical cancer data and cash runway outlook - Stock Titan

Apr 21, 2026

Apr 15, 2026

Foghorn Therapeutics (FHTX) Stock: Short-Term vs Long-Term (Eye on Rally) 2026-04-15Momentum Picks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 15, 2026

Apr 13, 2026

Foghorn (NASDAQ: FHTX) CEO shifts 213,410 shares in trust-to-trust gifts - Stock Titan

Apr 13, 2026

Apr 11, 2026

If You Invested $1,000 in Foghorn Therapeutics Inc. (FHTX) - Stock Titan

Apr 11, 2026

Apr 10, 2026

Trading Recap: Can Foghorn Therapeutics Inc weather a recession2026 Spike Watch & Technical Pattern Recognition Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting - Investing News Network

Apr 09, 2026

Apr 09, 2026

Foghorn to present preclinical cancer data at AACR meeting By Investing.com - Investing.com South Africa

Apr 09, 2026

Apr 09, 2026

Foghorn Therapeutics details preclinical advances across oncology programs - Traders Union

Apr 09, 2026

Apr 09, 2026

Foghorn to present preclinical cancer data at AACR meeting - Investing.com

Apr 09, 2026

Apr 09, 2026

Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor ... - Bluefield Daily Telegraph

Apr 09, 2026

Apr 09, 2026

Foghorn Therapeutics to Present New Preclinical Data for - GlobeNewswire

Apr 09, 2026

Apr 05, 2026

FHTX PE Ratio & Valuation, Is FHTX Overvalued - Intellectia AI

Apr 05, 2026

Apr 05, 2026

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Apr 05, 2026

Apr 02, 2026

FHTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 02, 2026

Apr 02, 2026

FHTX Stock Price, Quote & Chart | FOGHORN THERAPEUTICS INC (NASDAQ:FHTX) - ChartMill

Apr 02, 2026

Apr 02, 2026

FHTX SEC FilingsFoghorn Therapeutics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 02, 2026

Apr 01, 2026

Strength Observed in Dianthus Therapeutics, Inc. (DNTH): Will Its 5.6% Increase Lead to Further Gains? - Bitget

Apr 01, 2026

Apr 01, 2026

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength? - Yahoo! Finance Canada

Apr 01, 2026

Mar 31, 2026

FHTX Should I Buy - Intellectia AI

Mar 31, 2026

Mar 30, 2026

Aug Final Week: Can Foghorn Therapeutics Inc weather a recessionCPI Data & High Conviction Investment Ideas - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

Setup Watch: Is Foghorn Therapeutics Inc part of any major index2026 Price Action Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Mar 30, 2026

Mar 29, 2026

Contrasting Foghorn Therapeutics (NASDAQ:FHTX) and Rocket Pharmaceuticals (NASDAQ:RCKT) - Defense World

Mar 29, 2026

Mar 28, 2026

Fundamentals Check: Is Foghorn Therapeutics Inc stock a good dividend stock2026 Earnings Impact & Daily Profit Focused Stock Screening - baoquankhu1.vn

Mar 28, 2026

Mar 20, 2026

Ideas Watch: Is Foghorn Therapeutics Inc stock a hidden gem2026 Fundamental Recap & Safe Entry Point Identification - baoquankhu1.vn

Mar 20, 2026